Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Reata Pharmaceuticals Inc (RETA)  
$172.36 0.00 (0.00%) as of 4:30 Mon 9/25


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 31,730,000
Market Cap: 5.47(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $79.22 - $172.36
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Reata Pharmaceuticals is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapies. Co. focuses on therapeutics for the treatment of diseases with few or no approved therapies. Co.'s main programs are in rare forms of chronic kidney disease (CKD) and a rare neurological disease. Co.'s primary product candidates include bardoxolone methyl (bardoxolone) in patients with CKD caused by Alport syndrome and omaveloxolone in patients with a neurological disorder called Friedreich's ataxia. Both bardoxolone and omaveloxolone activate the transcription factor Nrf2 to normalize mitochondrial function, restore redox balance, and resolve inflammation.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 227,148 598,993
Total Sell Value $0 $0 $31,930,160 $63,982,389
Total People Sold 0 0 9 10
Total Sell Transactions 0 0 25 53
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 393
  Page 6 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Castellanos Elaine VP, Chief Accounting Officer   •       –      –    2021-05-26 4 S $124.55 $1,245,470 D/D (10,000) 14,546 20%     
   Castellanos Elaine VP, Chief Accounting Officer   •       –      –    2021-05-26 4 A $0.00 $0 D/D 10,000 24,546     -
   Cpmg Inc   •       •       •   2020-12-23 4 D $0.00 $0 I/I (166,666) 0     -
   Mcgaughy R Kent Jr   •       •       •   2020-12-23 4 D $0.00 $0 I/I (166,666) 2,896,901     -
   Castellanos Elaine VP, Chief Accounting Officer   •       –      –    2020-11-18 4 GD $0.00 $0 D/D 600 14,546     -
   Meyer Colin John Chief Research Officer   •       –      –    2020-11-17 4 S $164.44 $1,057,571 D/D (6,395) 72,000 42%     
   Meyer Colin John Chief Research Officer   •       –      –    2020-11-17 4 A $0.00 $0 D/D 6,395 78,395     -
   Meyer Colin John Chief Research Officer   •       –      –    2020-11-16 4 S $170.48 $3,181,577 D/D (18,605) 72,000 45%     
   Meyer Colin John Chief Research Officer   •       –      –    2020-11-16 4 A $0.00 $0 D/D 18,605 90,605     -
   Mcclellan William D. Jr. Director   –       •      –    2020-11-12 4 S $172.44 $691,669 D/D (4,000) 0 42%     
   Mcclellan William D. Jr. Director   –       •      –    2020-11-12 4 A $0.00 $0 D/D 4,000 4,000     -
   Castellanos Elaine VP, Chief Accounting Officer   •       –      –    2020-11-12 4 AS $176.02 $616,070 D/D (3,500) 15,146 -42%     
   Castellanos Elaine VP, Chief Accounting Officer   •       –      –    2020-11-12 4 A $0.00 $0 D/D 3,500 18,646     -
   Wortley Michael D Chief Legal Officer   •       –      –    2020-11-11 4 S $175.94 $9,224,669 D/D (51,429) 0 44%     
   Wortley Michael D Chief Legal Officer   •       –      –    2020-11-11 4 A $0.00 $0 D/D 51,429 51,429     -
   Huff James Warren Chief Executive Officer   •       •      –    2020-11-10 4 AS $175.00 $11,369,756 D/D (64,970) 0 -44%     
   Meyer Colin John Chief Research Officer   •       –      –    2020-11-09 4 AS $175.00 $4,375,000 D/D (25,000) 72,000 -38%     
   Huff James Warren Chief Executive Officer   •       •      –    2020-11-09 4 AS $175.06 $2,921,291 D/D (16,687) 64,970 -38%     
   Mcclellan William D. Jr. Director   –       •      –    2020-11-09 4 AS $150.01 $600,040 D/D (4,000) 0 -38%     
   Mcclellan William D. Jr. Director   –       •      –    2020-11-09 4 A $0.00 $0 D/D 4,000 4,000     -
   Bir Dawn Carter Chief Commercial Officer   •       –      –    2020-11-09 4 AS $150.01 $9,750,300 D/D (60,000) 0 -38%     
   Bir Dawn Carter Chief Commercial Officer   •       –      –    2020-11-09 4 A $0.00 $0 D/D 60,000 60,000     -
   Soni Manmeet Singh COO and CFO   •       –      –    2020-08-14 4 B $100.19 $300,630 D/D 3,000 3,000 2.74 27%     
   Castellanos Elaine VP, Chief Accounting Officer   •       –      –    2020-06-01 4 AS $143.97 $287,940 D/D (2,000) 15,146 -21%     
   Castellanos Elaine VP, Chief Accounting Officer   •       –      –    2020-06-01 4 A $0.00 $0 D/D 2,000 17,146     -
  393 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us